Liver Cancer
Copyright ©The Author(s) 2004.
World J Gastroenterol. Oct 1, 2004; 10(19): 2791-2794
Published online Oct 1, 2004. doi: 10.3748/wjg.v10.i19.2791
Table 1 Clinical and pathological characteristics in control and adjuvant TACE groups patients without risk factors for residual tumor
CharacteristicsControlAdjuvant TACEP value
(n = 174)group (n = 77)
Gender
Female3450.009
Male14072
Age (mean ± SD)50.86 ± 11.6149.35 ± 10.040.323
HBsAg
Positive43110.135
Negative13166
Cirrhosis
Absent2260.130
Mild5333
Severe9938
Child-pugh Class
A165770.134
B50
AFP (mean ± SD, ug/L)333.91 ± 529.92406.04 ± 735.160.381
TNM classification
I28190.108
II14658
Table 2 Clinical and pathological characteristics in control and adjuvant TACE groups patients with risk factors for re-sidual tumor
CharacteristicsControlAdjuvant TACE groupP value
(n = 190)(n = 108)
Gender
Female33120.147
Male15796
Age (mean ± SD)51.50 ± 11.7249.63 ± 10.070.105
HBsAg
Positive47270.588
Negative14381
Cirrhosis
Absent41240.563
Mild6945
Severe8039
Child-pugh Class
A1871060.860
B32
AFP (mean ± SD, μg/L)501.39 ± 807.14518.25 ± 707.990.856
TNM classification
II113660.926
IIIA5531
IVA2211
Table 3 Multivariate Cox proportional hazard analysis to evaluate independent variables in patients without risk fac-tors for residual tumor
VariablesBWaldSignificanceHR95%CI lower upper
Cirrhosis0.68914.4430.0001.9911.3962.841
Absent = 1
Mild = 2
Severe = 3
Tumor0.2356.0190.0141.2641.0481.525
diameter (cm)
Table 4 Multivariate Cox proportional hazard analysis to evaluate independent variables in patients with risk factors for residual tumor
VariablesBWaldSignificanceHR95% lower upper
AFP (μg/L)0.2125.3330.0211.2361.0331.480
< 20 = 1
21-400 = 2
> 400 = 3
Adjuvant TACE-0.4066.0410.0140.6660.4820.921
Without = 1
With = 2
Tumor diameter (cm)0.07616.3270.0001.0791.0401.119
Vascular invasion0.2457.6910.0061.2781.0751.520
Absent = 1
Present = 2